JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
MannKind Corp
MNKD
$1.24B
| $542K | ﹤0.01% |
147,318
+28,518
| +24% | +$104K |
|
4452
Invesco Mortgage Capital
IVR
$805M
| $541K | ﹤0.01% |
23,745
-111,341
| -82% | -$2.74M |
|
4453
Orrstown Financial Services
ORRF
$852M
| $541K | ﹤0.01% |
23,613
-13,229
| -36% | -$322K |
|
4454
PUT
Shopify
SHOP
$199B
| $541K | ﹤0.01% |
8,000
-14,000
| -64% | -$1.15M |
|
4455
Bain Capital Specialty
BCSF
$814M
| $540K | ﹤0.01% |
34,646
+9,528
| +38% | +$150K |
|
4456
Advantage Solutions
ADV
$420M
| $539K | ﹤0.01% |
3,376
-1,315
| -28% | -$228K |
|
4457
Southern Missouri Bancorp
SMBC
$845M
| $539K | ﹤0.01% |
10,794
-5,325
| -33% | -$283K |
|
4458
Cytek Biosciences
CTKB
$610M
| $538K | ﹤0.01% |
49,906
+39,974
| +402% | +$540K |
|
4459
First Trust Consumer Staples AlphaDEX Fund
FXG
$233M
| $532K | ﹤0.01% |
8,347
-355
| -4% | -$22.2K |
|
|
TA
4460
DELISTED
TravelCenters of America LLC
TA
| $532K | ﹤0.01% |
12,382
-17,507
| -59% | -$757K |
|
4461
BlueLinx
BXC
$680M
| $531K | ﹤0.01% |
7,380
-58,738
| -89% | -$4.81M |
|
4462
PUT
Steven Madden
SHOO
$3.45B
| $529K | ﹤0.01% |
13,700
| – | – |
|
4463
York Water
YORW
$541M
| $528K | ﹤0.01% |
11,727
-14,202
| -55% | -$634K |
|
4464
Anterix
ATEX
$1.79B
| $527K | ﹤0.01% |
9,116
-3,080
| -25% | -$168K |
|
4465
VirnetX Holding Corp
VHC
$62.8M
| $527K | ﹤0.01% |
16,161
-6,442
| -29% | -$263K |
|
|
INBX
4466
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $527K | ﹤0.01% |
23,614
-37,702
| -61% | -$962K |
|
|
HYZN
4467
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $525K | ﹤0.01% |
1,644
+610
| +59% | +$169K |
|
4468
TeraWulf
WULF
$8.67B
| $524K | ﹤0.01% |
+62,355
| New | +$683K |
|
4469
Arcutis Biotherapeutics
ARQT
$3.29B
| $520K | ﹤0.01% |
27,022
+4,646
| +21% | +$78.6K |
|
4470
ZipRecruiter
ZIP
$386M
| $519K | ﹤0.01% |
22,598
+19,529
| +636% | +$424K |
|
|
BELFB
4471
Bel Fuse Inc Class B
BELFB
$4.19B
| $518K | ﹤0.01% |
29,033
-251
| -0.9% | -$3.7K |
|
4472
Waterstone Financial
WSBF
$382M
| $515K | ﹤0.01% |
26,632
-16,874
| -39% | -$341K |
|
|
GGPI
4473
PUT
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
| $515K | ﹤0.01% |
+45,300
| New | +$502K |
|
|
DTRTU
4474
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
| $512K | ﹤0.01% |
50,000
-50,000
| -50% | -$505K |
|
|
SSAAU
4475
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
| $512K | ﹤0.01% |
52,075
| – | – |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.